Safety Measures for Medicinal Products
Article Sidebar
Main Article Content
Abstract
At present, defective medicinal products cause injuries to consumers in Thailand. Meanwhile, most of the existing legislation in Thailand, with respect to medicinal products, centres on product liability law and seeks to put in place remedial measures by providing compensation for harm caused to consumers by unsafe products. However, there are limitations of safety measures in Thailand, especially in terms of medicinal products, which will lead to the continuously raising of defective products in the market.
Therefore, it is essential to set forth safety measures for medicinal products as a preventive measure to protect consumers before defective products cause injuries. This article presents the legal problems of the current safety measures for medicinal products in Thailand and suggests effective solutions for enacting concrete safety measures for medicinal products.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Calnan N, Overview of the recent FDA Process Validation Guidance for Medicinal Product Development and Manufacture, PDA Ireland Symposium: Embracing the Challenges of Lifecycle Based Validation, (7th. 2013).
Hodge C, EUROPEAN regulation of Consumer Product Safety. (Oxford University Press, 2009).
Supanit S, Commentary on Consumer Protection Laws, (2014).
Code of Federal Regulations
Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use.
Drug Act of B.E.2510 (1967) (as amended in 2019)
Health Products (Therapeutic Products) Regulations 2016
Ministerial Regulation No. 20 (B.E. 2525) Issued under the Provisions of Drug Act B.E.2510 (1967)
Borisuttham S, Mattrakan Riekkheun Sinkha Pheua Kan Khumkhrong Phuboriphok [The Consumer Protection : Product Recall], (Thesis of Master of Laws, Thammasat University 2011) (สุทธินี บริสุทธิ์ธรรม, มาตรการเรียกคืนสินค้าเพื่อการคุ้มครองผู้บริโภค, มหาวิทยาลัยธรรมศาสตร์ 2554)
Chaichatchawan N, Kotmai Waduay Khwamplotphai Khong Sinkha [Product Safety Law], (Thesis of Master of Laws, Thammasat University 2013) (ณัฐพร ชัยชัชวาล, กฎหมายว่าด้วยความปลอดภัยของ สินค้า, มหาวิทยาลัยธรรมศาสตร์ 2556)
Health Product Vigilance Center, ‘The statistics of the HPVC reporting of all suspected adverse events of the health products in 1984-2019’ <http://thaihpvc.fda.moph.go.th/thaihvc/Public/News/uploads/hpvc_5_13_0_100805.pdf>, accessed on 11 October 2019.
Suwankesawong W, ‘Pharmacovigilance in Thailand’, <https://www.genome.gov/Multimedia/Slides/SJS_TEN2015/12_Sewankesawong.pdf> accessed 11 October 2019
U.S. Food and Drug Administration, ‘Postmarketing Safety Surveillance and Oversight: MedWatch, FAERS, and the Sentinel System’, <https://www.fda.gov/drugs/drugsafety/ucm522941.htm>, accessed 10 July 2019.
U.S. Food and Drug Administration, ‘The FDA's Drug Review Process: Ensuring Drugs Are Safe and Effective’, <https://www.fda.gov/ Drugs/ResourcesForYou/Consumers/ucm143534.htm>, accessed 10 July 2019.